Vancouver, BC (PRWEB) April 21, 2015 – According to a new report by iData Research (http://www.idataresearch.com), growth within the U.S. spinal implant market will largely be driven by new technologies and improvements in existing technologies. The most notable development in spinal implants is the increasing prevalence of motion preservation technology. Many companies are developing new minimally invasive products to make up for lost revenues in the markets for more traditional spinal fixation products.
Some spinal implant companies, however, have been struggling to put the newest technologies to market. “Both the NRD (nucleus replacement device) market and the facet arthroplasty market were expected to emerge sometime between 2013 and 2014,” explains Dr. Kamran Zamanian, CEO of iData Research. “However, FDA approval for these products has yet to be granted.”
Other key findings from the 2015 edition of the iData Research report entitled U.S. Market for Spinal Implants and VCF include:
Nucleus Replacement Device Market Uncertainty
Many NRD products are at various stages of clinical trials, but some are still in the investigational pre-clinical phase. It is unknown when these products will enter the market officially or if they will even have a significant impact on the markets for currently existing products.
Critical Journal Article Continues to Make Market Waves
The vertebral compression fracture market recently recovered from a study presented in the New England Journal of Medicine that showed no statistical difference between patients treated with vertebroplasty and those treated with a placebo procedure. When released, the study negatively affected both the vertebroplasty and percutaneous vertebral augmentation segments of the vertebral compression fracture (VCF) market. Since then, other studies have been carried out which suggest otherwise, aiding market recovery.
Leading Competitors
Medtronic leads the U.S. spinal implant market with over one third of the share. With the motion preservation, cervical fixation and electrical stimulation markets as the exceptions, this company leads every segment of the spinal implant market in which it actively competes. Medtronic gained the lead in both the VCF and motion preservation markets upon their acquisition of Kyphon in 2007.
With the merger of DePuy and Synthes under the Johnson &Johnson family in 2012, this entity has become the number one contender for Medtronic’s leading spot.
Other leading competitors in this market include Stryker, Zimmer, and Globus Medical, all of which compete directly with Medtronic in a number of spinal implant segments.
For Further Information
The report published by iData, entitled “U.S. Market for Spinal Implants and VCF,” covers the U.S. market as a whole, including market segments for cervical fixation, thoracolumbar fixation, interbody devices, motion preservation devices, vertebral compression fractures, and spinal electrical stimulation.
The global series on the spinal implant and VCF markets covers the U.S., Australia, Japan, South Korea, China, Taiwan, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
This iData report also includes extensive information on U.S. spinal implant procedure numbers.
Register online or email us at info(at)idataresearch(dot)net for a U.S. Market for Spinal Implants and VCF report brochure and synopsis.
About Procedure Tracker
Additional procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.